Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging

Summary

The purpose of this study is based on the Flutemetamol-PET senile plaque imaging to investigate the peripheral blood biochemical and brain MRI imaging biomarkers and to research completely independent intellectual property rights neuropsychological test tool for the MCI due to AD. At the same time, the investigators will study the efficacy and safety of early treatment of MCI due to AD by Huperzine A in 52 weeks.

Timeline

Start

2019-11

Primary completion

2024-12

Completion

2025-12

Drugs

Indications